• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqGM
    0.48 Down 0.01(2.85%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:0.49
    Open:0.50
    Bid:0.40 x 200
    Ask:N/A
    1y Target Est:4.50
    Beta:3.05
    Next Earnings Date:N/A
    Day's Range:0.47 - 0.51
    52wk Range:0.36 - 3.47
    Volume:745,770
    Avg Vol (3m):1,572,070
    Market Cap:44.37M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXDown 2.85%44.37M
    ASTM 0.00%65.77M
    BAXDown 0.05%40.35B
    OSIRUp 0.88%510.34M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.47
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback